186 related articles for article (PubMed ID: 12820316)
1. Diagnostic role of markers dipeptidyl peptidase IV and thyroid peroxidase in thyroid tumors.
Kholová I; Ludvíkova M; Ryska A; Topolcan O; Pikner R; Pecen L; Cáp J; Holubec L
Anticancer Res; 2003; 23(2A):871-5. PubMed ID: 12820316
[TBL] [Abstract][Full Text] [Related]
2. [CD26/dipeptidyl peptidase IV and thyroid peroxidase as molecular markers for differentiated thyroid carcinoma].
Umeki K; Yamamoto I; Maruta J; Aratake Y; Ono I; Uemura Y; Tanaka T; Toyoda K; Kotani T; Noguchi S; Sakamoto F; Konoe K; Ohtaki S
Rinsho Byori; 1996 Jan; 44(1):42-50. PubMed ID: 8691639
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical detection of dipeptidyl peptidase IV (CD 26) in thyroid neoplasia using biotinylated tyramine amplification.
Kholová I; Ludvíková M; Ryska A; Hanzelková Z; Cap J; Pecen L; Topolcan O
Neoplasma; 2003; 50(3):159-64. PubMed ID: 12937847
[TBL] [Abstract][Full Text] [Related]
4. [Dipeptidyl peptidase IV (DPP IV, CD 26): a tumor marker in cytologic and histopathologic diagnosis of lesions of the thyroid gland].
Kholová I; Ryska A; Ludvíková M; Pecen L; Cáp J
Cas Lek Cesk; 2003 Mar; 142(3):167-71. PubMed ID: 12756846
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of the thyroid peroxidase marker for distinguishing follicular thyroid carcinoma from follicular adenoma.
Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
Exp Oncol; 2006 Mar; 28(1):70-4. PubMed ID: 16614712
[TBL] [Abstract][Full Text] [Related]
6. Thyroperoxidase: a tumor marker for post-therapeutic follow-up of differentiated thyroid carcinomas? Results of a time course study.
Franke WG; Zöphel K; Wunderlich GR; Mat R; Kühne A; Schimming C; Kropp J; Bredow J
Cancer Detect Prev; 2000; 24(6):524-30. PubMed ID: 11198265
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic applicability of dipeptidyl aminopeptidase IV activity in cytological samples for differentiating follicular thyroid carcinoma from follicular adenoma.
Maruta J; Hashimoto H; Yamashita H; Yamashita H; Noguchi S
Arch Surg; 2004 Jan; 139(1):83-8. PubMed ID: 14718282
[TBL] [Abstract][Full Text] [Related]
8. [Thyroid papillary cancer using TPO staining].
Nygaard B; Frisch T; Kiss K
Ugeskr Laeger; 2008 Apr; 170(18):1571. PubMed ID: 18454932
[TBL] [Abstract][Full Text] [Related]
9. Human telomerase reverse transcriptase gene expression and the surgical management of suspicious thyroid tumors.
Umbricht CB; Conrad GT; Clark DP; Westra WH; Smith DC; Zahurak M; Saji M; Smallridge RC; Goodman S; Zeiger MA
Clin Cancer Res; 2004 Sep; 10(17):5762-8. PubMed ID: 15355904
[TBL] [Abstract][Full Text] [Related]
10. The use of a combination of galectin-3 and thyroid peroxidase for the diagnosis and prognosis of thyroid cancer.
Weber KB; Shroyer KR; Heinz DE; Nawaz S; Said MS; Haugen BR
Am J Clin Pathol; 2004 Oct; 122(4):524-31. PubMed ID: 15487449
[TBL] [Abstract][Full Text] [Related]
11. [Detection of cytokeratin 19 and thyroperoxidase expressions in the diagnosis of thyroid diseases].
Yang QX; Shao CK; Feng ZY; Huang BQ; Han AJ; Xiong M; Zhao WL; Wu TT
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun; 25(6):678-81. PubMed ID: 15958307
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic usefulness of dipeptidyl aminopeptidase IV monoclonal antibody in paraffin-embedded thyroid follicular tumours.
Kotani T; Asada Y; Aratake Y; Umeki K; Yamamoto I; Tokudome R; Hirai K; Kuma K; Konoe K; Araki Y
J Pathol; 1992 Sep; 168(1):41-5. PubMed ID: 1360496
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish between benign and malignant follicular neoplasias.
Belge G; Meyer A; Klemke M; Burchardt K; Stern C; Wosniok W; Loeschke S; Bullerdiek J
Genes Chromosomes Cancer; 2008 Jan; 47(1):56-63. PubMed ID: 17943974
[TBL] [Abstract][Full Text] [Related]
14. Is there loss or qualitative changes in the expression of thyroid peroxidase protein in thyroid epithelial cancer?
Czarnocka B; Pastuszko D; Janota-Bzowski M; Weetman AP; Watson PF; Kemp EH; McIntosh RS; Asghar MS; Jarzab B; Gubala E; Wloch J; Lange D
Br J Cancer; 2001 Sep; 85(6):875-80. PubMed ID: 11556840
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical loss of thyroid peroxidase in papillary thyroid carcinoma: strong suppression of peroxidase gene expression.
Tanaka T; Umeki K; Yamamoto I; Sugiyama S; Noguchi S; Ohtaki S
J Pathol; 1996 May; 179(1):89-94. PubMed ID: 8691351
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical demonstration of thyroid peroxidase (TPO) in human thyroid tissues from various thyroid diseases.
Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Nakamura S; Arai Y; Kotani T; Ohtaki S; Matsukawa S
Anticancer Res; 1994; 14(3B):1329-34. PubMed ID: 8067701
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of dipeptidyl peptidase IV (CD26) and thyroid peroxidase in neoplastic thyroid tissues.
Umeki K; Tanaka T; Yamamoto I; Aratake Y; Kotani T; Sakamoto F; Noguchi S; Ohtaki S
Endocr J; 1996 Feb; 43(1):53-60. PubMed ID: 8732452
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic utility of galectin-3 and CD26/DPPIV as preoperative diagnostic markers for thyroid nodules.
Aratake Y; Umeki K; Kiyoyama K; Hinoura Y; Sato S; Ohno A; Kuribayashi T; Hirai K; Nabeshima K; Kotani T
Diagn Cytopathol; 2002 Jun; 26(6):366-72. PubMed ID: 12112826
[TBL] [Abstract][Full Text] [Related]
19. [Tumor markers in the cytodiagnosis of thyroid nodules. Detection of dipeptidyl aminopeptidase IV (DAP IV) activity].
Zoro P; Vassko V; Garcia S; Pazart L; Aho S; De Micco C
Ann Pathol; 1996 Sep; 16(4):261-5. PubMed ID: 9172614
[TBL] [Abstract][Full Text] [Related]
20. Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation.
Savin S; Cvejic D; Isic T; Paunovic I; Tatic S; Havelka M
Hum Pathol; 2008 Nov; 39(11):1656-63. PubMed ID: 18657294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
